Sun Pharma amongst top 5% of global pharma companies in S&P Global Sustainability Yearbook 2025 Read more
No plans to enter vaccine production as it needs different manufacturing infra: Dilip Sanghvi Read more
Aim to gain market share, preserve cash, reduce overall debt in times of COVID-19: Dilip Shanghvi Read more